702 filings
Page 2 of 36
4
Singh Shawn
3 Jan 24
Vistagen Therapeutics / Shawn Singh ownership change
5:17pm
8-K
VTGN
VistaGen Therapeutics Inc
3 Jan 24
Vistagen Receives Notice from European Patent Office of Intention to Grant Patent for AV-101 to Treat Neuropathic Pain
5:09pm
10-Q
2024 Q2
VTGN
VistaGen Therapeutics Inc
Quarterly report
9 Nov 23
4:44pm
8-K
VTGN
VistaGen Therapeutics Inc
9 Nov 23
Vistagen Provides Corporate Update and Reports Fiscal 2024 Second Quarter Financial Results
4:42pm
8-K/A
VTGN
VistaGen Therapeutics Inc
6 Nov 23
Other Events
9:46pm
8-K
VTGN
VistaGen Therapeutics Inc
6 Nov 23
Other Events
4:27pm
3
Joshua S. Prince
3 Nov 23
Vistagen Therapeutics / Joshua S. Prince ownership change
8:14pm
8-K
VTGN
VistaGen Therapeutics Inc
26 Oct 23
Departure of Directors or Certain Officers
4:13pm
SC 13G
TCG Crossover GP II, LLC
16 Oct 23
Vistagen Therapeutics / TCG Crossover GP II ownership change
4:37pm
SC 13G
VTGN
VistaGen Therapeutics Inc
16 Oct 23
Vistagen Therapeutics / BIOTECHNOLOGY VALUE FUND L P ownership change
4:34pm
SC 13G
VTGN
VistaGen Therapeutics Inc
16 Oct 23
Vistagen Therapeutics / CITADEL ADVISORS ownership change
4:01pm
SC 13G
VTGN
VistaGen Therapeutics Inc
12 Oct 23
Vistagen Therapeutics / GREAT POINT PARTNERS ownership change
4:04pm
4
Commodore Capital LP
6 Oct 23
Change in insider ownership
4:05pm
SC 13G/A
Commodore Capital LP
6 Oct 23
Vistagen Therapeutics / COMMODORE CAPITAL ownership change
4:05pm
SC 13G
Point72 Asset Management, L.P.
5 Oct 23
Vistagen Therapeutics / Point72 Asset Management ownership change
4:47pm
8-K
VTGN
VistaGen Therapeutics Inc
4 Oct 23
Entry into a Material Definitive Agreement
4:07pm
424B5
VTGN
VistaGen Therapeutics Inc
3 Oct 23
Prospectus supplement for primary offering
4:40pm
8-K
VTGN
VistaGen Therapeutics Inc
2 Oct 23
Other Events
7:15am
8-K
VTGN
VistaGen Therapeutics Inc
29 Sep 23
Submission of Matters to a Vote of Security Holders
4:26pm
8-K
VTGN
VistaGen Therapeutics Inc
12 Sep 23
Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH80 for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder
8:43pm